Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of ANCA-associated vasculitis followed by SARS-CoV-2 vaccination in a patient with HLA-DRB1*09:01 allele.

Modern rheumatology case reports - 19 Jun 2023

Kawamura Takuro, Nakazawa Daigo, Nishio Saori, Isozaki Taiki, Komatsumoto Maki, Atsumi Tatsuya

Abstract excerpt

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presents with severe pneumonia and fatal systemic complications. Currently, SARS-CoV-2 vaccines are effective in reducing the risk of new onset and getting worse of the disease. However, autoimmune diseases such as antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have been reported to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Share to Antibodies, Antineutrophil Cytoplasmic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to COVID-19 Vaccines

Share to HLA-DRB1 Chains

Share to Peroxidase

Share to SARS-CoV-2

Share to Vaccination

Source

Identifiers

PMID: 36610742
DOI: 10.1093/mrcr/rxac093

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of ANCA-associated vasculitis followed by SARS-CoV-2 vaccination in a patient with HLA-DRB1*09:01 allele.PMID 36610742Read ↗

New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome.Semantic proximity Read ↗

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis.Semantic proximity Read ↗

Meta-analysis revealed HLA susceptibility markers in ANCA-associated vasculitis and its clinical subtypes.Semantic proximity Read ↗

Antineutrophil cytoplasm antibody-associated vasculitis: recent developments.Semantic proximity Read ↗

End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 vaccine mRNA-1273: A case report with literature revision.Semantic proximity Read ↗

Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.Semantic proximity Read ↗

Distinct HLA and non-HLA associations in different subtypes of ANCA-associated vasculitides in North India.Semantic proximity Read ↗

Genetics of ANCA-associated vasculitis in Japan: a role for HLA-DRB1*09:01 haplotype.Semantic proximity Read ↗

Type of ANCA may be Superior to Clinical Phenotype in Distinguishing Different Clinical Entities in ANCA-associated VasculitisSemantic proximity Read ↗

Pathogenesis of ANCA-associated vasculitis.Semantic proximity Read ↗

Antineutrophil cytoplasmic antibodies – their role in pathogenesis, diagnosis and treatment monitoring of ANCA-associated vasculitisSemantic proximity Read ↗

Association Between HLA-DPB1 and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.